Nov 23, 2017
This week on BrainWaves, we build on concepts introduced in
episode 65 regarding the non-pharmacologic management of
drug-resistant epilepsy. In the next two episodes, you'll hear from
Dr. Danielle Becker (Penn) and Dr. Myriam Abdennadher (NIH) on the
minimally invasive procedures that can drastically impact the lives
of patients with refractory seizures.
Produced by James E. Siegler. Music by Steve Combs, Jason Shaw,
and Josh Woodward. BrainWaves' podcasts and online content are
intended for medical education only and should not be used for
clinical decision making.
- Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W,
Mathern G, Moshe SL, Perucca E, Wiebe S and French J. Definition of
drug resistant epilepsy: consensus proposal by the ad hoc Task
Force of the ILAE Commission on Therapeutic Strategies.
- Nilsson L, Farahmand BY, Persson PG, Thiblin I and Tomson T.
Risk factors for sudden unexpected death in epilepsy: a
case-control study. Lancet. 1999;353:888-93.
- Tomson T, Nashef L and Ryvlin P. Sudden unexpected death in
epilepsy: current knowledge and future directions. The Lancet
- Willie JT, Laxpati NG, Drane DL, Gowda A, Appin C, Hao C, Brat
DJ, Helmers SL, Saindane A, Nour SG and Gross RE. Real-time
magnetic resonance-guided stereotactic laser amygdalohippocampotomy
for mesial temporal lobe epilepsy. Neurosurgery.
2014;74:569-84; discussion 584-5.